過敏性腸症候群（IBS）市場は、2023年から2028年の間に19億3,190万米ドル成長すると予測されており、予測期間中に9.3％のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。IBSの有病率の増加、IBSに対する認識と診断の高まり、世界のヘルスケア支出の増加が牽引しています。
この調査は、医薬品の承認数の増加が、今後数年間の過敏性腸症候群市場の成長を促進する主な理由の1つであることを特定しています。また、ベンダー間のパートナーシップや協力、IBSの治療法としてのアミトリプチリンの探索は、市場でかなりの需要につながるでしょう。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Irritable Bowel Syndrome Market 2018 - 2022
Historic Market Size - Data Table on Global Irritable Bowel Syndrome Market 2018 - 2022 ($ million)
5.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
5.3 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Irritable Bowel Syndrome Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 IBS-D - Market size and forecast 2023-2028
Chart on IBS-D - Market size and forecast 2023-2028 ($ million)
Data Table on IBS-D - Market size and forecast 2023-2028 ($ million)
Chart on IBS-D - Year-over-year growth 2023-2028 (%)
Data Table on IBS-D - Year-over-year growth 2023-2028 (%)
8.4 IBS-C - Market size and forecast 2023-2028
Chart on IBS-C - Market size and forecast 2023-2028 ($ million)
Data Table on IBS-C - Market size and forecast 2023-2028 ($ million)
Chart on IBS-C - Year-over-year growth 2023-2028 (%)
Data Table on IBS-C - Year-over-year growth 2023-2028 (%)
8.5 IBS-M - Market size and forecast 2023-2028
Chart on IBS-M - Market size and forecast 2023-2028 ($ million)
Data Table on IBS-M - Market size and forecast 2023-2028 ($ million)
Chart on IBS-M - Year-over-year growth 2023-2028 (%)
Data Table on IBS-M - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Drug Class
9.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
9.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
9.3 Antibiotics - Market size and forecast 2023-2028
Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
9.4 Guanylate cyclase-C agonists - Market size and forecast 2023-2028
Chart on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
Data Table on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
Chart on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
Data Table on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
9.5 Mu-opioid receptor agonists - Market size and forecast 2023-2028
Chart on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
Data Table on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
Chart on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
Data Table on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
9.6 Chloride channel activators - Market size and forecast 2023-2028
Chart on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
Data Table on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
Chart on Chloride channel activators - Year-over-year growth 2023-2028 (%)
Data Table on Chloride channel activators - Year-over-year growth 2023-2028 (%)
9.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
9.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ million)
Data Table on Market opportunity by Drug Class ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
11.12 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
11.13 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
11.14 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
11.15 Australia - Market size and forecast 2023-2028
Chart on Australia - Market size and forecast 2023-2028 ($ million)
Data Table on Australia - Market size and forecast 2023-2028 ($ million)
Chart on Australia - Year-over-year growth 2023-2028 (%)
Data Table on Australia - Year-over-year growth 2023-2028 (%)
11.16 Brazil - Market size and forecast 2023-2028
Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Chart on Brazil - Year-over-year growth 2023-2028 (%)
Data Table on Brazil - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
14.5 Alfasigma Spa
Alfasigma Spa - Overview
Alfasigma Spa - Product / Service
Alfasigma Spa - Key offerings
SWOT
14.6 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
14.7 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
14.8 Bausch Health Companies Inc.
Bausch Health Companies Inc. - Overview
Bausch Health Companies Inc. - Business segments
Bausch Health Companies Inc. - Key news
Bausch Health Companies Inc. - Key offerings
Bausch Health Companies Inc. - Segment focus
SWOT
14.9 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
14.10 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
14.11 Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc - Overview
Ironwood Pharmaceuticals Inc - Product / Service
Ironwood Pharmaceuticals Inc - Key offerings
SWOT
14.12 Mallinckrodt Plc
Mallinckrodt Plc - Overview
Mallinckrodt Plc - Business segments
Mallinckrodt Plc - Key news
Mallinckrodt Plc - Key offerings
Mallinckrodt Plc - Segment focus
SWOT
14.13 Nestle Health Science S.A.
Nestle Health Science S.A. - Overview
Nestle Health Science S.A. - Product / Service
Nestle Health Science S.A. - Key offerings
SWOT
14.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
14.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
14.17 Sebela Pharmaceuticals Inc.
Sebela Pharmaceuticals Inc. - Overview
Sebela Pharmaceuticals Inc. - Product / Service
Sebela Pharmaceuticals Inc. - Key offerings
SWOT
14.18 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2023 and 2028
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value Chain Analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits24: Historic Market Size - Data Table on Global Irritable Bowel Syndrome Market 2018 - 2022 ($ million)
Exhibits25: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits26: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits29: Five forces analysis - Comparison between 2023 and 2028
Exhibits30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits35: Chart on Market condition - Five forces 2023 and 2028
Exhibits36: Chart on Type - Market share 2023-2028 (%)
Exhibits37: Data Table on Type - Market share 2023-2028 (%)
Exhibits38: Chart on Comparison by Type
Exhibits39: Data Table on Comparison by Type
Exhibits40: Chart on IBS-D - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on IBS-D - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on IBS-D - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on IBS-D - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on IBS-C - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on IBS-C - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on IBS-C - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on IBS-C - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on IBS-M - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on IBS-M - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on IBS-M - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on IBS-M - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Type ($ million)
Exhibits53: Data Table on Market opportunity by Type ($ million)
Exhibits54: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits55: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by Drug Class
Exhibits57: Data Table on Comparison by Drug Class
Exhibits58: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Guanylate cyclase-C agonists - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Guanylate cyclase-C agonists - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Mu-opioid receptor agonists - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Mu-opioid receptor agonists - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
Exhibits71: Data Table on Chloride channel activators - Market size and forecast 2023-2028 ($ million)
Exhibits72: Chart on Chloride channel activators - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Chloride channel activators - Year-over-year growth 2023-2028 (%)
Exhibits74: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits75: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits76: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits78: Market opportunity by Drug Class ($ million)
Exhibits79: Data Table on Market opportunity by Drug Class ($ million)
Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits81: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits82: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits83: Chart on Geographic comparison
Exhibits84: Data Table on Geographic comparison
Exhibits85: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits115: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits117: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits118: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits119: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits120: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits121: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits122: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits123: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits124: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits125: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits126: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits127: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits128: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits129: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits133: Chart on Australia - Market size and forecast 2023-2028 ($ million)
Exhibits134: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
Exhibits135: Chart on Australia - Year-over-year growth 2023-2028 (%)
Exhibits136: Data Table on Australia - Year-over-year growth 2023-2028 (%)
Exhibits137: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits138: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits139: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits140: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits141: Market opportunity By Geographical Landscape ($ million)
Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits143: Impact of drivers and challenges in 2023 and 2028
Exhibits144: Overview on criticality of inputs and factors of differentiation
Exhibits145: Overview on factors of disruption
Exhibits146: Impact of key risks on business
Exhibits147: Companies covered
Exhibits148: Company ranking index
Exhibits149: Matrix on companies position and classification
Exhibits150: AbbVie Inc. - Overview
Exhibits151: AbbVie Inc. - Product / Service
Exhibits152: AbbVie Inc. - Key news
Exhibits153: AbbVie Inc. - Key offerings
Exhibits154: SWOT
Exhibits155: Alfasigma Spa - Overview
Exhibits156: Alfasigma Spa - Product / Service
Exhibits157: Alfasigma Spa - Key offerings
Exhibits158: SWOT
Exhibits159: Astellas Pharma Inc. - Overview
Exhibits160: Astellas Pharma Inc. - Product / Service
Exhibits161: Astellas Pharma Inc. - Key offerings
Exhibits162: SWOT
Exhibits163: AstraZeneca Plc - Overview
Exhibits164: AstraZeneca Plc - Product / Service
Exhibits165: AstraZeneca Plc - Key news
Exhibits166: AstraZeneca Plc - Key offerings
Exhibits167: SWOT
Exhibits168: Bausch Health Companies Inc. - Overview
Exhibits169: Bausch Health Companies Inc. - Business segments
Exhibits170: Bausch Health Companies Inc. - Key news
Exhibits171: Bausch Health Companies Inc. - Key offerings
Exhibits172: Bausch Health Companies Inc. - Segment focus
Exhibits173: SWOT
Exhibits174: Bayer AG - Overview
Exhibits175: Bayer AG - Business segments
Exhibits176: Bayer AG - Key news
Exhibits177: Bayer AG - Key offerings
Exhibits178: Bayer AG - Segment focus
Exhibits179: SWOT
Exhibits180: Boehringer Ingelheim International GmbH - Overview
Exhibits181: Boehringer Ingelheim International GmbH - Product / Service
Exhibits182: Boehringer Ingelheim International GmbH - Key news
Exhibits183: Boehringer Ingelheim International GmbH - Key offerings
Exhibits184: SWOT
Exhibits185: Ironwood Pharmaceuticals Inc - Overview
Exhibits186: Ironwood Pharmaceuticals Inc - Product / Service
Exhibits187: Ironwood Pharmaceuticals Inc - Key offerings
Exhibits188: SWOT
Exhibits189: Mallinckrodt Plc - Overview
Exhibits190: Mallinckrodt Plc - Business segments
Exhibits191: Mallinckrodt Plc - Key news
Exhibits192: Mallinckrodt Plc - Key offerings
Exhibits193: Mallinckrodt Plc - Segment focus
Exhibits194: SWOT
Exhibits195: Nestle Health Science S.A. - Overview
Exhibits196: Nestle Health Science S.A. - Product / Service
Exhibits197: Nestle Health Science S.A. - Key offerings
Exhibits198: SWOT
Exhibits199: Novartis AG - Overview
Exhibits200: Novartis AG - Business segments
Exhibits201: Novartis AG - Key news
Exhibits202: Novartis AG - Key offerings
Exhibits203: Novartis AG - Segment focus
Exhibits204: SWOT
Exhibits205: Pfizer Inc. - Overview
Exhibits206: Pfizer Inc. - Product / Service
Exhibits207: Pfizer Inc. - Key news
Exhibits208: Pfizer Inc. - Key offerings
Exhibits209: SWOT
Exhibits210: Sanofi SA - Overview
Exhibits211: Sanofi SA - Business segments
Exhibits212: Sanofi SA - Key news
Exhibits213: Sanofi SA - Key offerings
Exhibits214: Sanofi SA - Segment focus
Exhibits215: SWOT
Exhibits216: Sebela Pharmaceuticals Inc. - Overview
Exhibits217: Sebela Pharmaceuticals Inc. - Product / Service
Exhibits218: Sebela Pharmaceuticals Inc. - Key offerings
Exhibits219: SWOT
Exhibits220: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits221: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits222: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits223: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits224: SWOT
Exhibits225: Inclusions checklist
Exhibits226: Exclusions checklist
Exhibits227: Currency conversion rates for US$
Exhibits228: Research methodology
Exhibits229: Information sources
Exhibits230: Data validation
Exhibits231: Validation techniques employed for market sizing
Exhibits232: Data synthesis
Exhibits233: 360 degree market analysis
Exhibits234: List of abbreviations
